We’re looking for new Non-Executive Directors to help us make Wales the place of choice for health and social care investment. We need people with experience of the life sciences sector to provide strategic insight and support this bold vision.
Our organisation helps life science innovation to reach our health and social care frontline. It’s a particularly exciting time to join our team and make a genuine difference by creating physical and economic well-being for the people of Wales.
About the role
To support our strategic aims and objectives, we’re looking for people with experience and background across at least one of the following areas:
- Senior leadership roles in the medical technology sector
- Working in the innovation funding landscape, with experience of collaborative innovation and venture capital funding particularly desirable
- Precision medicine
- The NHS from a finance and procurement perspective
Your responsibilities will include:
- Analysing and critically reviewing complex information and contributing to sound decision-making, strategy development
- Advising our Board on key issues – offering your opinions and challenging when appropriate
- Supporting our CEO in appointing senior staff and mentoring existing staff
- Overseeing the effective stewardship of resources, ensuring openness and accountability in the allocation and utilisation of resources
- Advocating for our organisation across the life sciences sector
Becoming a Non-Executive Director also gives you the opportunity to create connections with people and organisations across the sector.
What is expected from a Non-Executive Director?
Board Members will need to be available to work for us a minimum of 12 days each year. The Board will meet at least six times a year.
You will be remunerated at a day rate of £282 up to a £15,000 per annum (pro rata) plus travel and subsistence.
Apply now!
For more details and to apply please visit the Welsh Government website.
Applications close on 1 May 2023. We expect interviews to be held during July 2023.